Dr. Reddy's enters into distribution partnership with Sanofi Healthcare India for vaccine brands
India, March 27 -- Hyderabad-based Dr. Reddy's Laboratories has entered into an exclusive partnership with Sanofi Healthcare India to promote and distribute their vaccine brands across private markets in India.
Under the arrangement, Dr. Reddy's will have exclusive rights to promote and distribute Sanofi's well established and trusted paediatric and adult vaccine brands Hexaxim(R), Pentaxim(R), Tetraxim(R), Menactra(R), FluQuadri(R), Adacel(R) and Avaxim(R) 80U. These brands saw combined sales of approx. Rs 426 crore (approx. $51 million) as per IQVIA MAT February 2024. Sanofi will continue to own, manufacture, and import these brands to the country.
M.V. Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets), Dr....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.